These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29038314)

  • 21. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.
    Tarnow L; Hildebrandt P; Hansen BV; Borch-Johnsen K; Parving HH
    Diabetologia; 2005 Jan; 48(1):149-55. PubMed ID: 15616804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of physical activity in chronic kidney disease in the presence of diabetes mellitus: a prospective cohort study.
    Wang IK; Tsai MK; Liang CC; Yen TH; Huang CC; Wen SF; Wen CP
    Am J Nephrol; 2013; 38(6):509-16. PubMed ID: 24356340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes Study.
    Lin CC; Chen CC; Kung PT; Li CI; Yang SY; Liu CS; Lin WY; Lee CC; Li TC; Kardia SL
    Cardiovasc Diabetol; 2012 Oct; 11():131. PubMed ID: 23083001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic kidney disease and mortality risk among older patients with type 2 diabetes mellitus (ZODIAC-24).
    Drion I; van Hateren KJ; Joosten H; Alkhalaf A; Groenier KH; Kleefstra N; Wetzels JF; Bilo HJ
    Age Ageing; 2012 May; 41(3):345-50. PubMed ID: 22314695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: a prospective observational study.
    Joly D; Choukroun G; Combe C; Dussol B; Fauvel JP; Halimi JM; Quéré S; Fiquet B
    Diabetes Res Clin Pract; 2015 Apr; 108(1):120-7. PubMed ID: 25726333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Frystyk J; Lajer M; Flyvbjerg A; Parving HH; Vionnet N; Rossing P
    Kidney Int; 2008 Sep; 74(5):649-54. PubMed ID: 18496510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
    Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
    Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
    Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes.
    Bjornstad P; Cree-Green M; Baumgartner A; Maahs DM; Cherney DZ; Pyle L; Regensteiner JG; Reusch JE; Nadeau KJ
    Diabetes Care; 2015 Jan; 38(1):126-31. PubMed ID: 25414156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere length predicts all-cause mortality in patients with type 1 diabetes.
    Astrup AS; Tarnow L; Jorsal A; Lajer M; Nzietchueng R; Benetos A; Rossing P; Parving HH
    Diabetologia; 2010 Jan; 53(1):45-8. PubMed ID: 19802713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.
    Mohammedi K; Potier L; Belhatem N; Matallah N; Hadjadj S; Roussel R; Marre M; Velho G
    Cardiovasc Diabetol; 2016 Jan; 15():5. PubMed ID: 26743116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.
    Harjutsalo V; Thomas MC; Forsblom C; Groop PH;
    Diabetes Obes Metab; 2018 Dec; 20(12):2759-2767. PubMed ID: 29962015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men.
    Ahola AJ; Harjutsalo V; Saraheimo M; Forsblom C; Groop PH;
    Diabetologia; 2012 Jan; 55(1):73-9. PubMed ID: 22033620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
    Skupien J; Warram JH; Smiles AM; Niewczas MA; Gohda T; Pezzolesi MG; Cantarovich D; Stanton R; Krolewski AS
    Kidney Int; 2012 Sep; 82(5):589-97. PubMed ID: 22622493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pattern-recognition molecule H-ficolin in relation to diabetic kidney disease, mortality, and cardiovascular events in type 1 diabetes.
    Østergaard JA; Jansson Sigfrids F; Forsblom C; Dahlström EH; Thorn LM; Harjutsalo V; Flyvbjerg A; Thiel S; Hansen TK; Groop PH
    Sci Rep; 2021 Apr; 11(1):8919. PubMed ID: 33903634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.